Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04342988 · ClinicalTrials.gov registry record · Phase 4
Effect of Cequa Treatment on Accuracy of Pre-operative Biometry & Higher Order Aberrations in Dry Eye Patients Undergoing Cataract Surgery
A Phase 4 study, sponsored by Research Insight.
- Completed
- Registry status
- Phase 4
- Development phase
- 74
- Enrollment target
NCT04342988 is a Phase 4 study that has completed, run by Research Insight. The registered enrollment target is 74 participants.
The verdict
NCT04342988, a Phase 4 study, has completed, sponsored by Research Insight.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 74 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effect of Cequa treatment on the accuracy of pre-operative biometry and on corneal higher-order aberrations (HOAs) in cataract patients who have signs of dry eye disease.
Interventions
- DRUG Cequa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2020-04-08 |
| Est. Completion | 2020-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04342988
The ClinicalTrials.gov registry entry for NCT04342988 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Research Insight, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cequa is the first listed.
NCT04342988 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04342988 about?
NCT04342988 is a clinical study titled "Effect of Cequa Treatment on Accuracy of Pre-operative Biometry & Higher Order Aberrations in Dry Eye Patients Undergoing Cataract Surgery". The purpose of this study is to examine the effect of Cequa treatment on the accuracy of pre-operative biometry and on corneal higher-order aberrations (HOAs) in cataract patients who have signs of dry eye disease.
What is the current status of trial NCT04342988?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 74 participants. The study started on 2020-04-08. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT04342988?
The interventions under investigation include: Cequa (DRUG).
Who is sponsoring clinical trial NCT04342988?
This trial is sponsored by Research Insight, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.